The DNA test kits market size has grown rapidly in recent years. It will grow from $1.74 billion in 2023 to $2.09 billion in 2024 at a compound annual growth rate (CAGR) of 19.7%. The growth observed in the historical period can be linked to several factors, including the upsurge in direct-to-consumer genetic tests, heightened demand for DNA testing related to health and fitness, the aging population, an uptick in cancer prevalence, and an increasing need for disease diagnostics.
The DNA test kits market size is expected to see rapid growth in the next few years. It will grow to $4.31 billion in 2028 at a compound annual growth rate (CAGR) of 19.9%. The projected growth in the forecast period can be attributed to several factors, including the escalating demand for personalized drug development, a heightened emphasis on personalized medicine, increased healthcare spending, rising interest in health-focused tests, a shift towards preventive healthcare measures, and a growing focus on population health management. Key trends anticipated in this period encompass advancements in genetic testing technologies, the proliferation of digital health platforms, widespread adoption of electronic medical records (EMRs), utilization of wearable devices, integration of artificial intelligence (AI) and machine learning algorithms, advancements in drug development, ecological monitoring applications, biodiversity assessment tools, and efforts in wildlife conservation.
The increasing prevalence of genetic disorders is anticipated to drive the growth of the DNA test kits market in the coming years. Genetic disorders, stemming from abnormalities in the genome, can manifest through mutations in single genes (monogenic), multiple genes (polygenic), or chromosomal anomalies. Contributing factors to this rise include heightened awareness, advancements in diagnostic methodologies, lifestyle changes, and environmental influences leading to genetic mutations. DNA test kits play a pivotal role in identifying specific gene mutations or variations associated with inherited conditions, facilitating diagnosis and personalized treatment strategies. For example, in April 2024, as reported by the Centers for Disease Control and Prevention (CDC), approximately 6,000 newborns, or one in 700 babies, are affected by Down syndrome annually. Additionally, according to the World Health Organization (WHO) in February 2023, congenital diseases account for an estimated 240,000 neonatal deaths globally within 28 days of birth each year. Hence, the escalating prevalence of genetic disorders is a key driver behind the growth of the DNA test kits market.
Prominent players in the DNA test kits market are concentrating on developing innovative offerings, such as personalized DNA kits, to gain a competitive edge. Personalized DNA kits analyze an individual's DNA to provide tailored insights into their health, ancestry, and traits. For instance, in April 2023, MapMyGenome, an India-based genomics company, introduced BeautyMap, India's inaugural DNA-based test kit offering personalized recommendations for skincare and haircare products based on an individual's genetic profile. The kit includes a complimentary genetic counseling session with a certified genetic counselor, facilitating interpretation of results and informed decision-making regarding a customized beauty regimen.
In January 2023, QIAGEN N.V., a Germany-based biotechnology company, acquired Verogen Inc. for $150 million. This acquisition enables QIAGEN to provide a comprehensive workflow in human identification and forensics, bolstering its capacity to support investigators and researchers in advancing forensic science and accurately identifying suspects. Verogen Inc., based in the United States, specializes in providing DNA test kits for forensic and human identification applications, aligning with QIAGEN's strategic objectives to expand its portfolio and capabilities in key segments of genetic testing.
Major companies operating in the DNA test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc., Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd., CENTOGENE N.V., Everlywell Inc., Gene by Gene Ltd., Zymo Research Corporation, Devyser, Living DNA Ltd, Veritas Genetics, Nebula Genomics.
North America was the largest region in the DNA test kits market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the DNA test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
DNA test kits consist of materials and instructions for collecting an individual's DNA sample, typically obtained through saliva or cheek swabs. These kits facilitate genetic testing for ancestry, health traits, and disease predispositions, with samples usually sent to laboratories for analysis, yielding personalized genetic insights.
Common sample types for DNA test kits include saliva, blood, tissue, teeth and bones, and hair. Saliva, a fluid produced by salivary glands in the mouth, contains water, proteins, salts, and enzymes. These kits cater to a range of applications such as ancestry tracing, dietary analysis, and disease risk assessment, and are utilized by various entities including hospitals, diagnostic and forensic laboratories, as well as academic and research institutions.
The DNA test kits market research report is one of a series of new reports that provides DNA test kits market statistics, including DNA test kits industry global market size, regional shares, competitors with a DNA test kits market share, detailed DNA test kits market segments, market trends and opportunities, and any further data you may need to thrive in the DNA test kits industry. This DNA test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The DNA test kits market consists of sales of DNA collection swabs, saliva collection tubes, transport tubes or containers, DNA sequencers, and DNA extraction and purification kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The DNA test kits market size is expected to see rapid growth in the next few years. It will grow to $4.31 billion in 2028 at a compound annual growth rate (CAGR) of 19.9%. The projected growth in the forecast period can be attributed to several factors, including the escalating demand for personalized drug development, a heightened emphasis on personalized medicine, increased healthcare spending, rising interest in health-focused tests, a shift towards preventive healthcare measures, and a growing focus on population health management. Key trends anticipated in this period encompass advancements in genetic testing technologies, the proliferation of digital health platforms, widespread adoption of electronic medical records (EMRs), utilization of wearable devices, integration of artificial intelligence (AI) and machine learning algorithms, advancements in drug development, ecological monitoring applications, biodiversity assessment tools, and efforts in wildlife conservation.
The increasing prevalence of genetic disorders is anticipated to drive the growth of the DNA test kits market in the coming years. Genetic disorders, stemming from abnormalities in the genome, can manifest through mutations in single genes (monogenic), multiple genes (polygenic), or chromosomal anomalies. Contributing factors to this rise include heightened awareness, advancements in diagnostic methodologies, lifestyle changes, and environmental influences leading to genetic mutations. DNA test kits play a pivotal role in identifying specific gene mutations or variations associated with inherited conditions, facilitating diagnosis and personalized treatment strategies. For example, in April 2024, as reported by the Centers for Disease Control and Prevention (CDC), approximately 6,000 newborns, or one in 700 babies, are affected by Down syndrome annually. Additionally, according to the World Health Organization (WHO) in February 2023, congenital diseases account for an estimated 240,000 neonatal deaths globally within 28 days of birth each year. Hence, the escalating prevalence of genetic disorders is a key driver behind the growth of the DNA test kits market.
Prominent players in the DNA test kits market are concentrating on developing innovative offerings, such as personalized DNA kits, to gain a competitive edge. Personalized DNA kits analyze an individual's DNA to provide tailored insights into their health, ancestry, and traits. For instance, in April 2023, MapMyGenome, an India-based genomics company, introduced BeautyMap, India's inaugural DNA-based test kit offering personalized recommendations for skincare and haircare products based on an individual's genetic profile. The kit includes a complimentary genetic counseling session with a certified genetic counselor, facilitating interpretation of results and informed decision-making regarding a customized beauty regimen.
In January 2023, QIAGEN N.V., a Germany-based biotechnology company, acquired Verogen Inc. for $150 million. This acquisition enables QIAGEN to provide a comprehensive workflow in human identification and forensics, bolstering its capacity to support investigators and researchers in advancing forensic science and accurately identifying suspects. Verogen Inc., based in the United States, specializes in providing DNA test kits for forensic and human identification applications, aligning with QIAGEN's strategic objectives to expand its portfolio and capabilities in key segments of genetic testing.
Major companies operating in the DNA test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc., Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd., CENTOGENE N.V., Everlywell Inc., Gene by Gene Ltd., Zymo Research Corporation, Devyser, Living DNA Ltd, Veritas Genetics, Nebula Genomics.
North America was the largest region in the DNA test kits market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the DNA test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
DNA test kits consist of materials and instructions for collecting an individual's DNA sample, typically obtained through saliva or cheek swabs. These kits facilitate genetic testing for ancestry, health traits, and disease predispositions, with samples usually sent to laboratories for analysis, yielding personalized genetic insights.
Common sample types for DNA test kits include saliva, blood, tissue, teeth and bones, and hair. Saliva, a fluid produced by salivary glands in the mouth, contains water, proteins, salts, and enzymes. These kits cater to a range of applications such as ancestry tracing, dietary analysis, and disease risk assessment, and are utilized by various entities including hospitals, diagnostic and forensic laboratories, as well as academic and research institutions.
The DNA test kits market research report is one of a series of new reports that provides DNA test kits market statistics, including DNA test kits industry global market size, regional shares, competitors with a DNA test kits market share, detailed DNA test kits market segments, market trends and opportunities, and any further data you may need to thrive in the DNA test kits industry. This DNA test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The DNA test kits market consists of sales of DNA collection swabs, saliva collection tubes, transport tubes or containers, DNA sequencers, and DNA extraction and purification kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. DNA Test Kits Market Characteristics3. DNA Test Kits Market Trends and Strategies32. Global DNA Test Kits Market Competitive Benchmarking33. Global DNA Test Kits Market Competitive Dashboard34. Key Mergers and Acquisitions in the DNA Test Kits Market
4. DNA Test Kits Market - Macro Economic Scenario
5. Global DNA Test Kits Market Size and Growth
6. DNA Test Kits Market Segmentation
7. DNA Test Kits Market Regional and Country Analysis
8. Asia-Pacific DNA Test Kits Market
9. China DNA Test Kits Market
10. India DNA Test Kits Market
11. Japan DNA Test Kits Market
12. Australia DNA Test Kits Market
13. Indonesia DNA Test Kits Market
14. South Korea DNA Test Kits Market
15. Western Europe DNA Test Kits Market
16. UK DNA Test Kits Market
17. Germany DNA Test Kits Market
18. France DNA Test Kits Market
19. Italy DNA Test Kits Market
20. Spain DNA Test Kits Market
21. Eastern Europe DNA Test Kits Market
22. Russia DNA Test Kits Market
23. North America DNA Test Kits Market
24. USA DNA Test Kits Market
25. Canada DNA Test Kits Market
26. South America DNA Test Kits Market
27. Brazil DNA Test Kits Market
28. Middle East DNA Test Kits Market
29. Africa DNA Test Kits Market
30. DNA Test Kits Market Competitive Landscape and Company Profiles
31. DNA Test Kits Market Other Major and Innovative Companies
35. DNA Test Kits Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
DNA Test Kits Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on DNA test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for DNA test kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The DNA test kits market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Sample Type: Saliva; Blood; Tissue; Teeth and Bone; Hairs; Other Sample Types2) by Application: Ancestry Testing; Diet and Nutrition; Disease Risk Assessment; Other Applications
3) by End User: Hospitals; Diagnostics and Forensics Laboratories; Academic and Research Institutes; Other End Users
Key Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton, Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Danaher Corporation
- Becton, Dickinson and Company
- GE HealthCare Technologies Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- Quest Diagnostics Incorporated
- Eurofins Scientific SE
- Agilent Technologies Inc.
- Illumina Inc.
- PerkinElmer Inc.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Natera Inc.
- Myriad Genetics Inc.
- BGI Genomics Co. Ltd.
- NeoGenomics Laboratories Inc.
- Ancestry.com LLC
- 23andMe Holding Co
- Ambry Genetics Corporation
- MyHeritage Ltd.
- CENTOGENE N.V.
- Everlywell Inc.
- Gene by Gene Ltd.
- Zymo Research Corporation
- Devyser
- Living DNA Ltd
- Veritas Genetics
- Nebula Genomics
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | June 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 2.09 Billion |
Forecasted Market Value ( USD | $ 4.31 Billion |
Compound Annual Growth Rate | 19.9% |
Regions Covered | Global |
No. of Companies Mentioned | 31 |